<DOC>
	<DOCNO>NCT01875939</DOCNO>
	<brief_summary>This study aim ascertain effect food pharmacokinetics WCK 2349 determine absolute bioavailability WCK 2349 1000 mg ( oral , QD dose ) respect WCK 771 800 mg ( intravenous , QD dose ) . This study would ascertain/confirm therapeutically equivalent oral IV dose WCK 2349 WCK 771 respectively , provide guidance case switch therapy ( WCK 771 , IV WCK 2349 , oral ) future clinical trial patient .</brief_summary>
	<brief_title>Phase I , Open Label , Crossover Food-Effect Absolute Bioavailability Study WCK2349 WCK771 Healthy Adult Human Volunteers</brief_title>
	<detailed_description>All subject checked-in clinical study facility Day -1 , day prior dose . The subject randomly assign receive WCK 2349 1000 mg oral dose feed fast state ( 1:1 ) food effect study per randomization schedule . The subject complete food effect study ( i.e. , Period 1 Period 2 ) administer WCK 771 800 mg intravenous infusion fast state Period 3 study . There washout period three day period . The subject continue remain clinical facility entire duration study ( completion three period study ) , include wash period . Prior check procedure , detailed clinical examination do confirm subject safety issue .</detailed_description>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>If female , postmenopausal least 1 year , surgically sterile birth control measure . Body Mass Index ( BMI ) 18 32 No significant diseases No recent history smoking alcohol Known history hypersensitivity idiosyncratic reaction quinolones relate drug . History evidence disease condition might compromise haemopoietic , renal , hepatic , endocrine , pulmonary , central nervous , cardiovascular , immunological , dermatological , gastrointestinal body system . No receipt prescription drug nonprescription drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>healthy volunteer</keyword>
</DOC>